PAPA Medical Inc.
PAPA
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 107.27% | 7.37% | 47.75% | 48.14% | 94.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 107.27% | 7.37% | 47.75% | 48.14% | 94.70% |
| Cost of Revenue | 114.96% | 8.17% | 48.04% | 60.37% | 93.18% |
| Gross Profit | 84.28% | 5.20% | 46.84% | 17.92% | 99.38% |
| SG&A Expenses | 79.91% | 46.85% | 74.41% | 126.77% | 223.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 108.01% | 17.44% | 53.11% | 69.87% | 108.98% |
| Operating Income | 94.73% | -166.38% | -17.74% | -64.15% | -10.01% |
| Income Before Tax | 102.36% | -181.32% | -24.02% | -65.17% | -3.29% |
| Income Tax Expenses | 22.69% | -223.98% | -22.78% | -72.56% | 36.43% |
| Earnings from Continuing Operations | 152.51% | -153.59% | -24.46% | -62.24% | -18.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 152.51% | -153.59% | -24.46% | -62.24% | -18.26% |
| EBIT | 94.73% | -166.38% | -17.74% | -64.15% | -10.01% |
| EBITDA | 103.88% | -99.29% | -11.27% | -60.42% | 0.60% |
| EPS Basic | 153.21% | -153.45% | -24.75% | -62.13% | -18.32% |
| Normalized Basic EPS | 105.66% | -166.29% | -24.28% | -65.08% | -3.64% |
| EPS Diluted | 153.21% | -153.45% | -24.75% | -62.13% | -18.32% |
| Normalized Diluted EPS | 105.66% | -166.29% | -24.28% | -65.08% | -3.64% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |